168
Views
4
CrossRef citations to date
0
Altmetric
Articles

Roles of arterial pressure volume index and arterial velocity pulse index trajectories in risk prediction in hypertensive patients with heart failure with preserved ejection fraction

ORCID Icon, , , , , , , , , & show all
Pages 469-478 | Received 22 Jul 2019, Accepted 15 Nov 2019, Published online: 18 Dec 2019

References

  • Gladden JD, Chaanine AH, Redfield MM. Heart failure with preserved ejection fraction. Annu Rev Med. 2018;69:65–79.doi:10.1146/annurev-med-041316-090654.
  • Guo L, Guo X, Chang Y, Yang J, Zhang L, Li T, Sun Y.Prevalence and risk factors of heart failure with preserved ejection fraction: a population-based study in Northeast China. Int J Environ Res Public Health. 2016;13(8):770–81.doi:10.3390/ijerph13080770.
  • Xin YG, Chen X, Zhao YN, Hu J, Sun Y, Hu WY.Outcomes of spironolactone treatment in patients in Northeast China suffering from heart failure with mid-range ejection fraction. Curr Med Res Opin. 2019;35(4):561–68.doi:10.1080/03007995.2018.1520695.
  • Wu S, Jin C, Li S, Zheng X, Zhang X, Cui L, Gao X.Aging, arterial stiffness, and blood pressure association in Chinese adults. Hypertension. 2019;73(4):893–99.doi:10.1161/HYPERTENSIONAHA.118.12396.
  • Tromp J, Teng TH, Tay WT, Hung CL, Narasimhan C, Shimizu W, Park SW, Liew HB, Ngarmukos T, Reyes EB, et al. Heart failure with preserved ejection fraction in Asia. Eur J Heart Fail. 2019;21(1):23–36.doi:10.1002/ejhf.1227.
  • Jackson JD, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ. Burden of heart failure on patients from China: results from a cross-sectional survey. Drug Des Devel Ther. 2018;12::1659–68.doi:10.2147/DDDT.S148949.
  • Reddy YNV, Andersen MJ, Obokata M, Koepp KE, Kane GC, Melenovsky V, Olson TP, Borlaug BA.Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2017;70(2):136–48.doi:10.1016/j.jacc.2017.05.029.
  • Pandey A, Khan H, Newman AB, Lakatta EG, Forman DE, Butler J, Berry JD.Arterial stiffness and risk of overall heart failure, heart failure with preserved ejection fraction, and heart failure with reduced ejection fraction: the health abc study (health, aging, and body composition). Hypertension. 2017;69(2):267–74.doi:10.1161/HYPERTENSIONAHA.116.08327.
  • Athyros VG, Pagourelias ED, Gossios TD, Vasilikos VG.Treating heart failure with preserved ejection fraction related to arterial stiffness. Can we kill two birds with one stone? Curr Vasc Pharmacol. 2015;13(3):368–80.doi:10.2174/1570161112666141126150948.
  • Tokitsu T, Yamamoto E, Hirata Y, Kusaka H, Fujisue K, Sueta D, Sugamura K, Sakamoto K, Tsujita K, Kaikita K, et al. Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction. Eur J Heart Fail. 2016;18(11):1353–61.doi:10.1002/ejhf.2016.18.issue-11.
  • Fraser AG, Gillebert TC, Leite-Moreira AF.Ventricular-arterial coupling in heart failure with preserved ejection fraction: the devil is in the details. Cardiovasc Res. 2017;113(8):844–46.doi:10.1093/cvr/cvx107.
  • Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail. 2016;18(6):588–98.doi:10.1002/ejhf.497.
  • Packer M, Kitzman DW.Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Fail. 2018;6(8):633–39.doi:10.1016/j.jchf.2018.01.009.
  • Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH.Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57(14):1511–22.doi:10.1016/j.jacc.2010.12.017.
  • Yamanashi H, Koyamatsu J, Nagayoshi M, Shimizu Y, Kawashiri SY, Kondo H, Fukui S, Tamai M, Maeda T.Screening Validity of Arterial Pressure-Volume Index and Arterial Velocity-Pulse Index for Preclinical Atherosclerosis in Japanese Community-Dwelling Adults: the Nagasaki Islands Study. J Atheroscler Thromb. 2018;25(9):792–98.doi:10.5551/jat.43125.
  • Komine H, Asai Y, Yokoi T, Yoshizawa M.Non-invasive assessment of arterial stiffness using oscillometric blood pressure measurement. Biomed Eng Online. 2012;11(1):6–18.doi:10.1186/1475-925X-11-6.
  • Tokitsu T, Yamamoto E, Oike F, Hirata Y, Tsujita K, Yamamuro M, Kaikita K, Hokimoto S.Clinical significance of brachial-ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction. J Hypertens. 2018;36(3):560–68.doi:10.1097/HJH.0000000000001589.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.doi:10.1093/eurheartj/ehw128.
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776–803.doi:10.1016/j.jacc.2017.04.025.
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248.doi:10.1016/j.jacc.2017.11.006.
  • Williams B, Mancia G, Spiering W, Agabiti RE, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021–104.
  • DeFilippis AP, Young R, Carrubba CJ, McEvoy JW, Budoff MJ, Blumenthal RS, Kronmal RA, McClelland RL, Nasir K, Blaha MJ.An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162(4):266–75.doi:10.7326/M14-1281.
  • Chen S, Li W, Jin C, Vaidya A, Gao J, Yang H, Wu S, Gao X.Resting heart rate trajectory pattern predicts arterial stiffness in a community-based Chinese cohort. Arterioscler Thromb Vasc Biol. 2017;37(2):359–64.doi:10.1161/ATVBAHA.116.308674.
  • Ravindrarajah R, Hazra NC, Hamada S, Charlton J, Jackson SHD, Dregan A, Gulliford MC.Systolic blood pressure trajectory, frailty, and all-cause mortality> 80 years of age: cohort study using electronic health records. Circulation. 2017;135(24):2357–68.doi:10.1161/CIRCULATIONAHA.116.026687.
  • Tartière-Kesri L, Tartière JM, Logeart D, Beauvais F, Cohen Solal A.Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2012;59(5):455–61.doi:10.1016/j.jacc.2011.10.873.
  • Chow B, Rabkin SW.The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev. 2015;20(3):291–303.doi:10.1007/s10741-015-9471-1.
  • Lu YC, Lyu P, Zhu HY, Xu DX, Tahir S, Zhang HF, Zhou F, Yao WM, Gong L, Zhou YL, et al. Brachial-ankle pulse wave velocity compared with mean arterial pressure and pulse pressure in risk stratification in a Chinese population. J Hypertens. 2018;36(3):528–36.doi:10.1097/HJH.0000000000001591.
  • Sasaki-Nakashima R, Kino T, Chen L, Doi H, Minegishi S, Abe K, Sugano T, Taguri M, Ishigami T. Successful prediction of cardiovascular risk by new non-invasive vascular indexes using suprasystolic cuff oscillometric waveform analysis. J Cardiol. 2017;69(1):30–37.doi:10.1016/j.jjcc.2016.06.004.
  • Obokata M, Reddy YNV, Melenovsky V, Kane GC, Olson TP, Jarolim P, Borlaug BA.Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2018;72(1):29–40.doi:10.1016/j.jacc.2018.04.039.
  • Liu X, Gu W, Li Z, Lei H, Li G, Huang W.Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update. J Hypertens. 2017;35(3):637–44.doi:10.1097/HJH.0000000000001203.
  • Lüscher TF.Heart failure with preserved ejection fraction: unravelling an enigma. Eur Heart J. 2018;39(30):2763–66.doi:10.1093/eurheartj/ehy520.
  • Leite S, Rodrigues S, Tavares-Silva M, Oliveira-Pinto J, Alaa M, Abdellatif M, Fontoura D, Falcão-Pires I, Gillebert TC, Leite-Moreira AF, et al. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2015;309(10):H1648–H1654.doi:10.1152/ajpheart.00397.2015.
  • Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, Beussink-Nelson L, Fermer ML, Broberg MA, Gan LM, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439–50.doi:10.1093/eurheartj/ehy531.
  • Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM.Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–59.doi:10.1056/NEJMoa052256.
  • Nadruz W Jr, West E, Santos M, Skali H, Groarke JD, Forman DE, Shah AM.Heart failure and midrange ejection fraction: implications of recovered ejection fraction for exercise tolerance and outcomes. Circ Heart Fail. 2016;9(4):e002826.doi:10.1161/CIRCHEARTFAILURE.115.002826.
  • Tripepi G, Agharazii M, Pannier B, D’Arrigo G, Mallamaci F, Zoccali C, London G.Pulse wave velocity and prognosis in end-stage kidney disease. Hypertension. 2018;71(6):1126–32.doi:10.1161/HYPERTENSIONAHA.118.10930.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.